5 new weight-loss drugs to watch in fight for next Ozempic
Lost and found: Life after Ozempic and other weight-loss drugs was just the start for these four people
Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage chronic conditions such as diabetes and heart disease and others to help them lose weight.
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...
1don MSN
The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...
A Goldman Sachs economist has suggested that the US economy could experience accelerated growth with increased use of GLP-1 ...
The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...
The more people who take GLP-1 weight-loss drugs, the faster the US economy could grow, a Goldman Sachs analyst said in a note last month. The US GDP could grow by an extra 1% if 60 million ...
The best online providers offer strong support services to help you succeed in your GLP-1 weight loss journey.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback